The Double Marker Test is a vital prenatal screening procedure conducted during the first trimester of pregnancy. It measures specific markers in the mother's blood—Free Beta-hCG and PAPP-A—to assess the risk of chromosomal abnormalities in the fetus, such as Down syndrome (Trisomy 21) and Edwards syndrome (Trisomy 18). This non-invasive test, combined with maternal age and ultrasound findings, provides valuable information to expectant parents, enabling them to make informed decisions about their pregnancy and consider further diagnostic testing if necessary.